Molecular Mechanisms of Autoimmune Heart Disease
Molecular Mechanisms of Autoimmune Heart Disease
批准号:
7228543
负责人:
MYRA A LIPES
金额:
$46.58万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2004
资助国家:
美国
项目状态:
已结题
起止时间:
2004-07-15 至 2010-05-31
关键词:
Activities of Daily LivingAdjuvantAffectAnimal ModelAutoantibodiesAutoimmune DiseasesAutoimmune ProcessAutoimmunityCD4 Positive T LymphocytesCardiacCardiac MyocytesCardiac MyosinsCardiomyopathiesCeliac DiseaseCellsCessation of lifeCharacteristicsChildClassCollaborationsCongenic StrainDevelopmentDiabetes MellitusDiagnosisDilated CardiomyopathyDiseaseEpitopesEtiologyExhibitsFrequenciesGenesGenotypeHLA-DQ8 antigenHaplotypesHeartHeart DiseasesHeart failureHospitalsHumanImmunizationImmunoglobulin GImmunologic TestsImmunologistInbred NOD MiceInfectionInsulin-Dependent Diabetes MellitusInterferon Type IIInterferonsInterleukin-4LeadLesionLymphocytic InfiltrateMHC Class II GenesMediatingMediator of activation proteinMethodsModelingMolecularMusMyocarditisMyocardiumMyosin ATPaseMyosin Heavy ChainsOrganPathogenesisPatientsPhenotypeProcessResistanceSecondary toSelf ToleranceSkeletal Muscle MyosinsSkeletal systemSpecificityStagingSubgroupSudden DeathSusceptibility GeneT-LymphocyteThinkingTransgenic OrganismsVirusVirus DiseasesWomancytokinehuman diseaseimprovedin vivoresponsetranslational studyyoung adult
中文摘要
描述(由申请人提供):自身免疫性心肌炎是儿童和年轻人猝死的主要原因。虽然被广泛认为是感染性病因,但在大多数情况下,疾病的原因是未知的。我们已经发现,在缺乏内源性鼠II类基因的非肥胖糖尿病小鼠中,人类HLA II类分子HLA-DQ 8的表达导致自身免疫性心肌炎的自发发展。疾病的特征是由于心力衰竭导致的过早死亡、心肌中的破坏性淋巴细胞浸润和针对心肌肌球蛋白重链的循环IgG自身抗体,类似于人类心肌炎。对直接从心脏病变中分离的CD 4 T细胞克隆的分析表明,与与骨骼肌和心肌肌球蛋白交叉反应的自身抗体相反,CD 4 T细胞仅识别心肌肌球蛋白,这与这种自身免疫性疾病过程的心脏特异性一致。这些克隆产生大量的干扰素-γ,但不产生IL-4,与致病性Th 1表型一致。该项目的具体目标是:1)使用T细胞克隆作为功能探针来鉴定与心肌细胞自身耐受性丧失有关的肌球蛋白3蛋白的表位,2)鉴定参与疾病发病机制的主要细胞介质,并使用同源菌株来确定1型糖尿病和自身免疫性心肌炎是否由共同的“自身免疫基因”控制,3)研究人类心肌炎是否是与HLA-DQ 8相关的器官特异性自身免疫性疾病,以及是否可以通过HLA分型和免疫学检测相结合来检测。这些转化研究将涉及PI与Brigham and Women's Hospital高级心脏病部主任Kenneth Baughman博士以及心肌炎领域的领导者之间的合作。这些研究的结果可能为人类心肌炎的病因学打开一个新的窗口,并导致诊断和治疗这种严重疾病的方法得到改进。
英文摘要
DESCRIPTION (provided by applicant): Autoimmune myocarditis is a major cause of sudden death in children and young adults. Although widely thought to be of infectious etiology, in the majority of cases the cause of disease is unknown. We have discovered that expression of the human HLA class II molecule, HLA-DQ8, in nonobese diabetic mice that lack endogenous murine class II genes results in the spontaneous development of autoimmune myocarditis. Disease was characterized by premature death due to heart failure, destructive lymphocytic infiltrates in the myocardium, and circulating IgG autantibodies against cardiac myosin heavy chain, similar to human myocarditis. Analysis of CD4 T cell clones isolated directly from the heart lesions reveals that, in contrast to the autoantibodies that cross-react with skeletal and cardiac myosin, the CD4 T cells recognize only cardiac myosin, consistent with the cardiac-specificity of this autoimmune disease process. These clones produce large amounts of interferon-gamma, but not IL-4, consistent with a pathogenic Th1 phenotype. The specific aims of this project are: 1) to use the T cell clones a functional probes to identify the epitopes of the myosin 3rotein that are reponsible for the loss of self-tolerance to cardiac myocytes, 2) to identify the primary cellular mediators involved in the pathogenesis of disease and to use congenic strains to determine whether type 1 diabetes and autoimmune myocarditis are controlled by common 'autoimmunity genes', 3) to investigate whether myocarditis in humans is an organ-specific autoimmune disease associated with HLA-DQ8 and whether it can be detected with a combination of HLA typing and immunological testing. These translational studies will involve a collaboration between the PI and Dr. Kenneth Baughman, Director of the Advanced Heart Disease Division at Brigham and Women's Hospital and a leader in the field of myocarditis. The results of these studies could open a new window into the etiology of human myocarditis and lead to improved methods to diagnose and treat this serious disease.
期刊论文(3)
专著(0)
科研奖励(0)
会议论文
DOI:
10.1126/scitranslmed.3003551
发表时间:
2012-06-13
期刊:
Science translational medicine
影响因子:
17.1
作者:
[Gottumukkala RV, Lv H, Cornivelli L, Wagers AJ, Kwong RY, Bronson R, Stewart GC, Schulze PC, Chutkow W, Wolpert HA, Lee RT, Lipes MA]
通讯作者:
Lipes MA
Cardiac Autoimmunity as a Mediator of Cardiovascular Outcomes in Type 1 Diabetes
-
批准号:10427400
-
项目类别:
-
资助金额:$37.02万
-
财政年份:2020
-
负责人:MYRA A LIPES
-
依托单位:
Cardiac Autoimmunity as a Mediator of Cardiovascular Outcomes in Type 1 Diabetes
-
批准号:10252880
-
项目类别:
-
资助金额:$37.82万
-
财政年份:2020
-
负责人:MYRA A LIPES
-
依托单位:
Cardiac Autoimmunity as a Mediator of Cardiovascular Outcomes in Type 1 Diabetes
-
批准号:10034461
-
项目类别:
-
资助金额:$39.28万
-
财政年份:2020
-
负责人:MYRA A LIPES
-
依托单位:
Cardiac Autoantibodies as Biomarkers for Heart Disease in Type 1 Diabetes
-
批准号:9186538
-
项目类别:
-
资助金额:$37.77万
-
财政年份:2015
-
负责人:MYRA A LIPES
-
依托单位:
Autoimmune Mechanisms in the Progression of CVD in Type 1 Diabetes
-
批准号:7422281
-
项目类别:
-
资助金额:$38.32万
-
财政年份:2005
-
负责人:MYRA A LIPES
-
依托单位:
Autoimmune Mechanisms /Progression of CVD in Type 1 Diab
-
批准号:6957327
-
项目类别:
-
资助金额:$39.98万
-
财政年份:2005
-
负责人:MYRA A LIPES
-
依托单位:
Autoimmune Mechanisms in the Progression of CVD in T1D
-
批准号:7095062
-
项目类别:
-
资助金额:$38.32万
-
财政年份:2005
-
负责人:MYRA A LIPES
-
依托单位:
Autoimmune Mechanisms in the Progression of CVD in Type 1 Diabetes
-
批准号:7233948
-
项目类别:
-
资助金额:$38.14万
-
财政年份:2005
-
负责人:MYRA A LIPES
-
依托单位:
Autoimmune Mechanisms in the Progression of CVD in Type 1 Diabetes
-
批准号:7619576
-
项目类别:
-
资助金额:$39.29万
-
财政年份:2005
-
负责人:MYRA A LIPES
-
依托单位:
Molecular Mechanisms of Autoimmune Heart Disease
-
批准号:7074056
-
项目类别:
-
资助金额:$46.67万
-
财政年份:2004
-
负责人:MYRA A LIPES
-
依托单位:
Molecular Mechanisms of Autoimmune Heart Disease
-
批准号:6811518
-
项目类别:
-
资助金额:$46.87万
-
财政年份:2004
-
负责人:MYRA A LIPES
-
依托单位:
Molecular Mechanisms of Autoimmune Heart Disease
-
批准号:6917869
-
项目类别:
-
资助金额:$46.5万
-
财政年份:2004
-
负责人:MYRA A LIPES
-
依托单位:
A cell-based glucose sensing and insulin delivery system
-
批准号:6789310
-
项目类别:
-
资助金额:$47.99万
-
财政年份:2002
-
负责人:MYRA A LIPES
-
依托单位:
A cell-based glucose sensing and insulin delivery system
-
批准号:6666748
-
项目类别:
-
资助金额:$46.57万
-
财政年份:2002
-
负责人:MYRA A LIPES
-
依托单位:
A cell-based glucose sensing and insulin delivery system
-
批准号:6589133
-
项目类别:
-
资助金额:$46.67万
-
财政年份:2002
-
负责人:MYRA A LIPES
-
依托单位:
BIOENGINEERING AN ARTIFICIAL BETA CELL
-
批准号:6564350
-
项目类别:
-
资助金额:$21.13万
-
财政年份:2001
-
负责人:MYRA A LIPES
-
依托单位:
BIOENGINEERING AN ARTIFICIAL BETA CELL
-
批准号:6410355
-
项目类别:
-
资助金额:$18.0万
-
财政年份:2000
-
负责人:MYRA A LIPES
-
依托单位:
BIOENGINEERING AN ARTIFICIAL BETA CELL
-
批准号:6414898
-
项目类别:
-
资助金额:$21.13万
-
财政年份:2000
-
负责人:MYRA A LIPES
-
依托单位:
CORE--TRANSGENIC MOUSE FACILITY
-
批准号:6420534
-
项目类别:
-
资助金额:$12.36万
-
财政年份:2000
-
负责人:MYRA A LIPES
-
依托单位:
HLA DQ TRANSGENIC MICE AS MODEL FOR DIABETES
-
批准号:6201296
-
项目类别:
-
资助金额:$17.41万
-
财政年份:1999
-
负责人:MYRA A LIPES
-
依托单位:
海外基金